Product Overview
NATtrol™ SARS-CoV-2 (recombinant) Stock is designed to evaluate the performance of nucleic acid tests for determination of the presence of SARS-CoV-2 N gene. NATtrol™ SARS-CoV-2 (recombinant) Stock can also be used for validation of clinical assays, development of diagnostic tests and training of laboratory personnel.
